Line 1: |
Line 1: |
| + | ==Acknowledgement== |
| + | This list is based on the [http://www.mayomedicallaboratories.com/articles/features/hem-cyto/index.html '''Mayo Clinic Hematologic Cytogenetics Reference Sheet, November 2012''']. |
| + | |
| __TOC__ | | __TOC__ |
| | | |
Line 12: |
Line 15: |
| |[[Translocation der(1)t(1;1)(p36;q21)|der(1)t(1;1)(p36;q21)]] | | |[[Translocation der(1)t(1;1)(p36;q21)|der(1)t(1;1)(p36;q21)]] |
| |[[NHL]] | | |[[NHL]] |
| + | | |
| |- | | |- |
| |[[Translocation t(1;3)(p36;q21)|t(1;3)(p36;q21)]] | | |[[Translocation t(1;3)(p36;q21)|t(1;3)(p36;q21)]] |
− | |[[MDS]],[[ AML]] | + | |[[MDS]],[[AML]] |
| |[[PRDM16(MEL1)-RPN1]] | | |[[PRDM16(MEL1)-RPN1]] |
| |- | | |- |
− | |[[t(1;3;5)(p36;p21;q33) ]] | + | |[[t(1;3;5)(p36;p21;q33)]] |
| |[[CEL]] | | |[[CEL]] |
| |[[WDR48-PDGFRB]] | | |[[WDR48-PDGFRB]] |
Line 26: |
Line 30: |
| |- | | |- |
| |[[t(1;5)(q22;q33)]] | | |[[t(1;5)(q22;q33)]] |
− | |[[MPD with eosinophilia]],[[ CEL]],[[ B-ALL]] | + | |[[MPD]],[[ CEL]],[[ B-ALL]] |
| |[[PDE4DIP-PDGFRB]] | | |[[PDE4DIP-PDGFRB]] |
| |- | | |- |
| |[[der(1;7)(q10;p10)]] | | |[[der(1;7)(q10;p10)]] |
− | |[[MDS]],[[ AML]],[[ MPD]] | + | |[[MDS]],[[AML]],[[ MPD]] |
| + | | |
| |- | | |- |
| |[[t(1;8)(p13;q24.1)]] | | |[[t(1;8)(p13;q24.1)]] |
− | |Missing | + | | |
− | | [[MYC(C-MYC)]] | + | |[[MYC]] |
| |- | | |- |
| |[[t(1;14)(q21;q32)]] | | |[[t(1;14)(q21;q32)]] |
− | |[[B-ALL]],[[ NHL]] | + | |[[B-ALL]],[[NHL]] |
− | |[[BCL9-IGH]],[[ FCGR2B-IGH]],[[ FCRL4-IGH]],[[ MUC1/IGH]] | + | |[[IGH-BCL9]],[[IGH-FCGR2B]],[[IGH-FCRL4]],[[IGH-MUC1]] |
| |- | | |- |
| |[[t(1;19)(q23;p13.3) ]] | | |[[t(1;19)(q23;p13.3) ]] |
| |[[B-ALL]] | | |[[B-ALL]] |
− | |[[PBX1-TCF3(E2A)]] | + | |[[TCF3(E2A)-PBX1]] |
| + | |- |
| + | |[[Translocation der(16)t(1;16)(q21;q11.2)|der(16)t(1;16)(q21;q11.2)]] |
| + | | |
| + | | |
| |- | | |- |
| |[[der(1;22)(q10;p10)]] | | |[[der(1;22)(q10;p10)]] |
| + | | |
| + | | |
| |- | | |- |
| |[[t(2;5)(p23;q35)]] | | |[[t(2;5)(p23;q35)]] |
− | |[[ALCL]],[[ NHL]] | + | |[[ALCL]],[[NHL]] |
− | |[[ALK-NPM1]] | + | |[[NPM1-ALK]] |
| |- | | |- |
| |[[t(2;8)(p12;q24.1)]] | | |[[t(2;8)(p12;q24.1)]] |
− | |[[BL]],[[ B-ALL]],[[ NHL ]] | + | |[[BL]],[[ B-ALL]],[[NHL]] |
− | |[[MYC(C-MYC)]] | + | |[[MYC]] |
| |- | | |- |
| |[[t(2;11)(p21;q23)]] | | |[[t(2;11)(p21;q23)]] |
− | |[[MDS]],[[ AML]],[[ B-ALL]] | + | |[[MDS]],[[AML]],[[B-ALL]] |
− | |[[MLL]] | + | |[[KMT2A]] |
| |- | | |- |
| |[[t(2;14)(p15;q32)]] | | |[[t(2;14)(p15;q32)]] |
− | |[[CLL]],[[ NHL]],[[ B-ALL]],[[ T-ALL]],[[ AML]] | + | |[[CLL]],[[ NHL]],[[ B-ALL]],[[ T-ALL]],[[AML]] |
| + | | |
| |- | | |- |
− | |[[t(3;3)(q21;q26.2) ]] | + | |[[Translocation t(3;3)(q21;q26.2) and Inversion inv(3)(q21q26.2)|t(3;3)(q21;q26.2)]] |
− | |[[MDS]],[[ AML]] | + | |[[MDS]],[[AML]] |
| |[[RPN1-MECOM(EVI1)]] | | |[[RPN1-MECOM(EVI1)]] |
| |- | | |- |
| |[[t(3;5)(p21-25;q32-35)]] | | |[[t(3;5)(p21-25;q32-35)]] |
| |[[MPD]] | | |[[MPD]] |
− | |[[GOLGA4-PDGFRB ]] | + | |[[GOLGA4-PDGFRB]] |
| |- | | |- |
| |[[t(3;21)(q26.2;q22)]] | | |[[t(3;21)(q26.2;q22)]] |
Line 75: |
Line 87: |
| |[[t(4;11)(q21;q23)]] | | |[[t(4;11)(q21;q23)]] |
| |[[B-ALL]],[[ T-ALL]] | | |[[B-ALL]],[[ T-ALL]] |
− | |[[AFF1(AF4)-MLL]] | + | |[[KMT2A-AFF1]] |
| |- | | |- |
| |[[t(4;14)(p16.3;q32)]] | | |[[t(4;14)(p16.3;q32)]] |
| |[[MM]] | | |[[MM]] |
− | |[[ FGFR3-IGH]] | + | |[[IGH-FGFR3]] |
| |- | | |- |
| |[[t(4;22)(q12;q11)]] | | |[[t(4;22)(q12;q11)]] |
| |[[atypical MPD]] | | |[[atypical MPD]] |
− | |[[ PDGFRA -BCR]] | + | |[[BCR-PDGFRA]] |
| |- | | |- |
| |[[t(4;5;5)(q23;q31;q33)]] | | |[[t(4;5;5)(q23;q31;q33)]] |
− | |[[chronic basophilic leukemia]] | + | |[[Chronic Basophilic Leukemia]] |
| |[[PRKG2-PDGFRB]] | | |[[PRKG2-PDGFRB]] |
| |- | | |- |
Line 102: |
Line 114: |
| |- | | |- |
| |[[t(5;12)(q33;q24)]] | | |[[t(5;12)(q33;q24)]] |
− | |[[MPD with eosinophilia ]] | + | |[[MPD]] |
| |[[GIT2-PDGFRB]] | | |[[GIT2-PDGFRB]] |
| |- | | |- |
| |[[t(5;12)(q33;p13)]] | | |[[t(5;12)(q33;p13)]] |
− | |[[CMML]],[[ MDS]],[[ MPD]] | + | |[[CMML]],[[MDS]],[[MPD]] |
| |[[ETV6(TEL)-PDGFRB]] | | |[[ETV6(TEL)-PDGFRB]] |
| |- | | |- |
| |[[t(5;14)(q33;q24)]] | | |[[t(5;14)(q33;q24)]] |
− | |[[MPD]],[[ atypical MPD]] | + | |[[MPD]],[[MPD]] |
| |[[NIN-PDGFRB]] | | |[[NIN-PDGFRB]] |
| |- | | |- |
| |[[t(5;14)(q33;q32)]] | | |[[t(5;14)(q33;q32)]] |
| + | | |
| |[[CCDC88C(KIAA1509)-PDGFRB]] | | |[[CCDC88C(KIAA1509)-PDGFRB]] |
| |- | | |- |
| |[[t(5;15)(q33;q22)]] | | |[[t(5;15)(q33;q22)]] |
− | |[[CMML atypical MPD]] | + | |[[CMML]],[[MPD]] |
| |[[TP53BP1-PDGFRB]] | | |[[TP53BP1-PDGFRB]] |
| |- | | |- |
Line 129: |
Line 142: |
| |- | | |- |
| |[[der(5;17)(p10;q10)]] | | |[[der(5;17)(p10;q10)]] |
− | |[[MDS]],[[ AML]] | + | |[[MDS]],[[AML]] |
| |[[NPM1(NPM)-RARA]] | | |[[NPM1(NPM)-RARA]] |
| |- | | |- |
Line 137: |
Line 150: |
| |- | | |- |
| |[[t(5;17)(q33;p13)]] | | |[[t(5;17)(q33;p13)]] |
− | |[[CMML]],[[ atypical MPD]] | + | |[[CMML]],[[MPD]] |
| |[[RABEP1-PDGFRB ]] | | |[[RABEP1-PDGFRB ]] |
| |- | | |- |
| |[[der(6)t(1;6)(q21;p21.3)]] | | |[[der(6)t(1;6)(q21;p21.3)]] |
| |[[PMF]] | | |[[PMF]] |
| + | | |
| |- | | |- |
| |[[t(6;9)(p23;q34) ]] | | |[[t(6;9)(p23;q34) ]] |
− | |[[MDS]],[[ AML]] | + | |[[MDS]],[[AML]] |
| |[[DEK-NUP214 (CAN)]] | | |[[DEK-NUP214 (CAN)]] |
| |- | | |- |
| |[[t(6;11)(q27;q23) ]] | | |[[t(6;11)(q27;q23) ]] |
− | |[[AML]],[[ t-AML]],[[ T-ALL]] | + | |[[AML]],[[ t-AML]],[[T-ALL]] |
− | |[[MLLT4(AF6)-MLL]] | + | |[[KMT2A-MLLT4]] |
| |- | | |- |
| |[[t(7;11)(p15;p15)]] | | |[[t(7;11)(p15;p15)]] |
Line 157: |
Line 171: |
| |[[t(8;14)(q24.1;q32) ]] | | |[[t(8;14)(q24.1;q32) ]] |
| |[[BL]],[[ B-ALL]],[[ NHL]] | | |[[BL]],[[ B-ALL]],[[ NHL]] |
− | |[[MYC(C-MYC)- IGH]] | + | |[[IGH-MYC]] |
| |- | | |- |
− | |[[t(8;16)(p11.2;p13.3) A]] | + | |[[t(8;16)(p11.2;p13.3)]] |
− | |[[AML M4]],[[ M5a]],[[ M5b]],[[ t-MDS]] | + | |[[AML]],[[t-MDS]] |
| |[[KAT6A(MYST3)-CREBBP(CBP)]] | | |[[KAT6A(MYST3)-CREBBP(CBP)]] |
| |- | | |- |
| |[[t(8;21)(q22;q22) A ]] | | |[[t(8;21)(q22;q22) A ]] |
− | |[[AML M2 mostly]],[[ rarely M1]],[[ M4]] | + | |[[AML]] |
| |[[RUNX1(AML)-RUNX1T1(ETO)]] | | |[[RUNX1(AML)-RUNX1T1(ETO)]] |
| |- | | |- |
| |[[t(8;22)(q24.1;q11.2) ]] | | |[[t(8;22)(q24.1;q11.2) ]] |
− | |[[BL]],[[ B-ALL]],[[ NHL]],[[ MM]] | + | |[[BL]],[[ B-ALL]],[[NHL]],[[ MM]] |
− | |[[MYC(C-MYC)-IGL(IGL)]] | + | |[[IGL-MYC]] |
| |- | | |- |
| |[[add(9)(p24)]] | | |[[add(9)(p24)]] |
| + | | |
| |[[JAK2]] | | |[[JAK2]] |
| |- | | |- |
| |[[t(9;11)(p22;q23)]] | | |[[t(9;11)(p22;q23)]] |
− | |[[AML mostly M5]],[[ M4]],[[ B-ALL]] | + | |[[AML]],[[B-ALL]] |
− | |[[MLLT3(AF9)-MLL]] | + | |[[KMT2A-MLLT3]] |
| |- | | |- |
| |[[t(9;14)(p13;q32)]] | | |[[t(9;14)(p13;q32)]] |
− | |[[MM]],[[ CLL]],[[ DLBCL]],[[ FL]],[[ MCL splenic MZL]] | + | |[[MM]],[[CLL]],[[DLBCL]],[[FL]],[[MCL splenic MZL]] |
| |[[PAX5-IGH]] | | |[[PAX5-IGH]] |
| |- | | |- |
− | |[[t(9;22)(q34;q11.2) A B ]] | + | |[[t(9;22)(q34;q11.2)]] |
− | |[[CML]],[[ B-ALL]],[[ T-ALL]] | + | |[[CML]],[[ B-ALL]],[[T-ALL]] |
| |[[ABL1(ABL)-BCR]] | | |[[ABL1(ABL)-BCR]] |
| |- | | |- |
− | |[[t(11;14)(q13;q32) A ]] | + | |[[t(11;14)(q13;q32)]] |
| |[[MCL]],[[ MM]] | | |[[MCL]],[[ MM]] |
− | |[[CCND1(BCL1)- IGH]] | + | |[[IGH-CCND1]] |
| |- | | |- |
| |[[t(11;14)(q23;q32)]] | | |[[t(11;14)(q23;q32)]] |
− | |[[t-AML]] | + | |[[AML]] |
− | |[[MLL-KIAA0284]] | + | |[[KMT2A-KIAA0284]] |
| |- | | |- |
| |[[t(11;16)(q23;p13.3)]] | | |[[t(11;16)(q23;p13.3)]] |
Line 206: |
Line 221: |
| |[[BIRC3(API2)-MALT1]] | | |[[BIRC3(API2)-MALT1]] |
| |- | | |- |
− | |[[t(11;19)(q23;p13.1) ]] | + | |[[t(11;19)(q23;p13.1)]] |
| |[[AML]] | | |[[AML]] |
− | |[[MLL-ELL]] | + | |[[KMT2A-ELL]] |
| |- | | |- |
− | |[[t(11;19)(q23;p13.3) ]] | + | |[[t(11;19)(q23;p13.3)]] |
− | |[[B-ALL]],[[ AML]],[[ T-ALL]] | + | |[[B-ALL]],[[AML]],[[T-ALL]] |
− | |[[MLL-MLLT1(ENL)]] | + | |[[KMT2A-MLLT1]] |
| |- | | |- |
| |[[t(14;16)(q32;q23)]] | | |[[t(14;16)(q32;q23)]] |
Line 218: |
Line 233: |
| |[[IGH-MAF]] | | |[[IGH-MAF]] |
| |- | | |- |
− | |[[t(14;18)(q32;q21) ]] | + | |[[t(14;18)(q32;q21)]] |
− | |[[BL]],[[ DLBCL]],[[ FL]],[[ CLL]] | + | |[[BL]],[[DLBCL]],[[FL]],[[CLL]] |
| |[[IGH-BCL2]] | | |[[IGH-BCL2]] |
| |- | | |- |
| |[[t(14;19)(q32;q13.3)]] | | |[[t(14;19)(q32;q13.3)]] |
− | |[[CLL]],[[ DLBCL]],[[ MCL]],[[ MZL]],[[ SLVL]] | + | |[[CLL]],[[DLBCL]],[[MCL]],[[MZL]],[[SLVL]] |
| + | |[[IGH-BCL3]] |
| |- | | |- |
| |[[t(14;19)(q32;q13)]] | | |[[t(14;19)(q32;q13)]] |
Line 247: |
Line 263: |
| |[[der(Y)t(Y;1)(q12;q12) ]] | | |[[der(Y)t(Y;1)(q12;q12) ]] |
| |[[MDS]] | | |[[MDS]] |
− | | + | | |
| |} | | |} |
| | | |
Line 259: |
Line 275: |
| |'''GENES''' | | |'''GENES''' |
| |- | | |- |
− | |[[inv(3)(q21q26.2) ]] | + | |[[Translocation t(3;3)(q21;q26.2) and Inversion inv(3)(q21q26.2)|inv(3)(q21q26.2)]] |
| |[[MDS]],[[ AML]] | | |[[MDS]],[[ AML]] |
| |[[RPN1-MECOM(EVI1)]] | | |[[RPN1-MECOM(EVI1)]] |
Line 273: |
Line 289: |
| |[[inv(16)(p13.1q22)]] | | |[[inv(16)(p13.1q22)]] |
| |[[AML M4Eo]] | | |[[AML M4Eo]] |
− | |[[MYH11]],[[ CBFB]] | + | |[[MYH11-CBFB]] |
| |} | | |} |
| | | |
Line 340: |
Line 356: |
| |- | | |- |
| |[[i(11)(q10) ]] | | |[[i(11)(q10) ]] |
− | |[[AML M2]],[[AML M4]],[[ MDS]] | + | |[[AML]],[[AML]],[[ MDS]] |
| | | | | |
| |- | | |- |
| |[[i(17)(q10)]] | | |[[i(17)(q10)]] |
− | |[[MDS]],[[ MPD]],[[ AML]],[[ CML]],[[ B-ALL]],[[ CLL]],[[ Hodgkin and NHL]] | + | |[[MDS]],[[ MPD]],[[ AML]],[[ CML]],[[ B-ALL]],[[CLL]],[[ Hodgkin and NHL]] |
| | | | | |
| |- | | |- |
| |[[i(21)(q10)]] | | |[[i(21)(q10)]] |
− | |[[B-ALL]],[[ MDS]],[[ NHL]],[[ AML]],[[ CMML]] | + | |[[B-ALL]],[[ MDS]],[[ NHL]],[[AML]],[[ CMML]] |
| | | | | |
| |- | | |- |
| |[[idic(X)(q13)]] | | |[[idic(X)(q13)]] |
− | |[[AML M1]],[[ M2]],[[ M4]],[[ MDS]],[[ RARS]] | + | |[[AML]],[[MDS]],[[RARS]] |
| |[[XIST]] | | |[[XIST]] |
| |} | | |} |
Line 371: |
Line 387: |
| |[[t(X;14) and t(Y;14)]] | | |[[t(X;14) and t(Y;14)]] |
| |[[B-ALL]] | | |[[B-ALL]] |
− | |[[IGH-CRLF2]] | + | |[[T(X;14) and t(Y;14)|IGH-CRLF2]] |
| |- | | |- |
| |[[t(5;14)(q35;q32)]] | | |[[t(5;14)(q35;q32)]] |
Line 378: |
Line 394: |
| |- | | |- |
| |[[del(1)(p32p32)]] | | |[[del(1)(p32p32)]] |
− | |[[B-ALL]] | + | |[[T-ALL]] |
− | |[[TAL1-STIL]] | + | |[[SIL(STIL)-TAL1]] |
| |} | | |} |
| | | |
Line 404: |
Line 420: |
| |- | | |- |
| |[[del(3)(p13p21)]] | | |[[del(3)(p13p21)]] |
− | | + | | |
| + | | |
| |- | | |- |
| |[[del(3)(q21)]] | | |[[del(3)(q21)]] |
Line 440: |
Line 457: |
| |[[del(6)(q21)]] | | |[[del(6)(q21)]] |
| |[[CLL]],[[ atypical CLL]],[[ AML]],[[ childhood B-ALL]],[[ childhood T-ALL]],[[ adult ALL]],[[ MM]] | | |[[CLL]],[[ atypical CLL]],[[ AML]],[[ childhood B-ALL]],[[ childhood T-ALL]],[[ adult ALL]],[[ MM]] |
| + | | |
| |- | | |- |
| |[[del(7)(p15)]] | | |[[del(7)(p15)]] |
| + | | |
| + | | |
| |- | | |- |
| |[[del(7)(p13) ]] | | |[[del(7)(p13) ]] |
| |[[AML]],[[ NHL]] | | |[[AML]],[[ NHL]] |
| + | | |
| |- | | |- |
| |[[del(7)(p13p15)]] | | |[[del(7)(p13p15)]] |
− | | + | | |
| + | | |
| |- | | |- |
| |[[del(7)(p11.2)]] | | |[[del(7)(p11.2)]] |
| |[[B-ALL]],[[ AML]],[[ MDS]] | | |[[B-ALL]],[[ AML]],[[ MDS]] |
| + | | |
| |- | | |- |
| |[[del(7)(q11.2)]] | | |[[del(7)(q11.2)]] |
| |[[B-ALL]],[[ AML]],[[ MDS]] | | |[[B-ALL]],[[ AML]],[[ MDS]] |
− | | + | | |
| |- | | |- |
| |[[del(7)(q22q34)]] | | |[[del(7)(q22q34)]] |
| |[[AML]],[[ MDS]],[[ NHL]] | | |[[AML]],[[ MDS]],[[ NHL]] |
− | | + | | |
| |- | | |- |
| |[[del(7)(q32q34)]] | | |[[del(7)(q32q34)]] |
| |[[AML]],[[ MDS]],[[ NHL]] | | |[[AML]],[[ MDS]],[[ NHL]] |
− | | + | | |
| |- | | |- |
| |[[del(7)(q32)]] | | |[[del(7)(q32)]] |
| |[[AML]],[[ MDS]],[[ NHL]] | | |[[AML]],[[ MDS]],[[ NHL]] |
| + | | |
| |- | | |- |
| |[[del(8)(p21)]] | | |[[del(8)(p21)]] |
| + | | |
| + | | |
| |- | | |- |
| |[[del(8)(q22)]] | | |[[del(8)(q22)]] |
| + | | |
| + | | |
| |- | | |- |
| |[[del(9)(p13)]] | | |[[del(9)(p13)]] |
| |[[B-ALL]],[[ NHL]],[[ pediatric B-ALL ]] | | |[[B-ALL]],[[ NHL]],[[ pediatric B-ALL ]] |
− | | + | | |
| |- | | |- |
| |[[del(9)(p13p22)]] | | |[[del(9)(p13p22)]] |
| |[[B-ALL]] | | |[[B-ALL]] |
| + | | |
| |- | | |- |
| |[[del(9)(p21)]] | | |[[del(9)(p21)]] |
| |[[B-ALL]],[[ AML]],[[ NHL]] | | |[[B-ALL]],[[ AML]],[[ NHL]] |
− | | + | | |
| |- | | |- |
| |[[del(9)(p22)]] | | |[[del(9)(p22)]] |
| |[[B-ALL]] | | |[[B-ALL]] |
− | | + | | |
| |- | | |- |
| |[[del(9)(q13)]] | | |[[del(9)(q13)]] |
| |[[AML M1]],[[ M2]],[[ M4]],[[ M6]] | | |[[AML M1]],[[ M2]],[[ M4]],[[ M6]] |
− | | + | | |
| |- | | |- |
| |[[del(9)(q13q22)]] | | |[[del(9)(q13q22)]] |
| |[[AML]],[[ MDS]] | | |[[AML]],[[ MDS]] |
− | | + | | |
| |- | | |- |
| |[[del(10)(q24)]] | | |[[del(10)(q24)]] |
− | | + | | |
| + | | |
| |- | | |- |
| |[[del(11)(p11.2)]] | | |[[del(11)(p11.2)]] |
| |[[NHL]] | | |[[NHL]] |
− | | + | | |
| |- | | |- |
| |[[del(11)(p12p13)]] | | |[[del(11)(p12p13)]] |
Line 506: |
Line 536: |
| |- | | |- |
| |[[del(11)(q13)]] | | |[[del(11)(q13)]] |
− | |Missing | + | | |
| + | | |
| |- | | |- |
| |[[del(11)(q13q21)]] | | |[[del(11)(q13q21)]] |
− | |Missing | + | | |
| + | | |
| |- | | |- |
| |[[del(11)(q13q23)]] | | |[[del(11)(q13q23)]] |
Line 529: |
Line 561: |
| |[[del(13)(q12q14)]] | | |[[del(13)(q12q14)]] |
| |[[AML]],[[ AMM]],[[ MDS]],[[ NHL]] | | |[[AML]],[[ AMM]],[[ MDS]],[[ NHL]] |
− | | + | | |
| |- | | |- |
| |[[del(13)(q12q22)]] | | |[[del(13)(q12q22)]] |
| |[[AML]],[[ PMF]],[[ CLL]],[[ MM]],[[ MDS]],[[ NHL]] | | |[[AML]],[[ PMF]],[[ CLL]],[[ MM]],[[ MDS]],[[ NHL]] |
| + | | |
| |- | | |- |
| |[[del(14)(q24) ]] | | |[[del(14)(q24) ]] |
| |[[NHL]] | | |[[NHL]] |
| + | | |
| |- | | |- |
| |[[del(16)(q22)]] | | |[[del(16)(q22)]] |
− | |[[AML]],[[ AML-M4Eo]],[[ NHL]] | + | |[[AML]],[[AML-M4Eo]],[[ NHL]] |
− | | + | | |
| |- | | |- |
| |[[del(17)(p11.2)]] | | |[[del(17)(p11.2)]] |
Line 547: |
Line 581: |
| |[[del(18)(q21)]] | | |[[del(18)(q21)]] |
| |[[AML]],[[ NHL]] | | |[[AML]],[[ NHL]] |
− | | + | | |
| + | |- |
| + | |[[del(20)(q11.2q13.1)]] |
| + | | |
| + | | |
| |- | | |- |
− | |[[del(20)(q11.2q13.1) | + | |[[del(20)(q11.2q13.3)]] |
− | del(20)(q11.2q13.3)]] | + | |[[AML]],[[MDS]],[[MPD]] |
− | |[[AML]],[[ MDS]],[[ MPD]] | + | | |
| |- | | |- |
| |[[ider(20)(p11.1)del(20)(q11.2q13.3)]] | | |[[ider(20)(p11.1)del(20)(q11.2q13.3)]] |
| |[[AML]],[[ MDS]],[[ MPD]] | | |[[AML]],[[ MDS]],[[ MPD]] |
− | |[[" | + | | |
| |- | | |- |
| |[[del(X)(q24)]] | | |[[del(X)(q24)]] |
| |[[NHL]] | | |[[NHL]] |
− | | + | | |
| |} | | |} |
| | | |
Line 569: |
Line 607: |
| |'''ANOMALY''' | | |'''ANOMALY''' |
| |'''ASSOCIATED DISORDERS with FISH test''' | | |'''ASSOCIATED DISORDERS with FISH test''' |
− | |'''GENES'''
| |
| |- | | |- |
| |[[+3]] | | |[[+3]] |
Line 599: |
Line 636: |
| |- | | |- |
| |[[+15]] | | |[[+15]] |
− | |Age related when sole anomaly or with -Y | + | |[[Age Related]] when sole anomaly or with [[-Y]] |
| |- | | |- |
| |[[+19]] | | |[[+19]] |
Line 610: |
Line 647: |
| |[[AML-M4eo]] | | |[[AML-M4eo]] |
| |- | | |- |
− | |[[-7 A B]] | + | |[[-7]] |
− | |[[MDS]],[[ RAEB/RAEB±T]],[[ CMML]],[[ J-CML]],[[ AML most often M4 or M6.]] | + | |[[MDS]],[[RAEB/RAEB±T]],[[CMML]],[[J-CML]],[[AML most often M4 or M6.]] |
| |- | | |- |
| |[[-Y ]] | | |[[-Y ]] |
− | |age related when sole anomaly | + | |[[Age Related]] when sole anomaly |
| | | |
| |} | | |} |
Line 637: |
Line 674: |
| |[[t(8;14)(q11;q32)]] | | |[[t(8;14)(q11;q32)]] |
| |[[B-ALL]] | | |[[B-ALL]] |
− | |[[CEBPD-IGH]] | + | |[[IGH-CEBPB]] |
| |- | | |- |
| |[[i(9)(q10)/idic(9)(q10)]] | | |[[i(9)(q10)/idic(9)(q10)]] |
| |[[B-ALL]] | | |[[B-ALL]] |
| + | | |
| |- | | |- |
| |[[dic(9;12)(p11;p11.2)]] | | |[[dic(9;12)(p11;p11.2)]] |
| |[[B-ALL]] | | |[[B-ALL]] |
| + | | |
| |- | | |- |
| |[[dic(9;20)(p11;q11)]] | | |[[dic(9;20)(p11;q11)]] |
Line 680: |
Line 719: |
| |[[T-ALL]] | | |[[T-ALL]] |
| |[[LMO2(Rhom2)-TRA]] | | |[[LMO2(Rhom2)-TRA]] |
− |
| |
| |} | | |} |
− | ==Acknowledgements==
| |
− | This list is based on the Mayo clinic Hematologic Cytogenetics Reference Sheet, November 2012
| |